Navigation Links
Onyx Pharmaceuticals Reports Second Quarter and Six-Month 2008 Financial Results
Date:8/5/2008

,021)

Provision (benefit) for income taxes (60) - 249 -

------ ------ ------ ------

Net income (loss) $4,474 $(10,826) $19,892 $(23,021)

------ ------ ------ ------

Net income (loss) per share:

Basic $0.08 $(0.22) $0.36 $(0.49)

------ ------- ------ -------

Diluted $0.08 $(0.22) $0.35 $(0.49)

------ ------- ------ -------

Shares used in computing net income

(loss) per share:

Basic 55,675 48,242 55,531 47,265

------ ------ ------ ------

Diluted 56,472 48,242 56,534 47,265

------ ------ ------ ------

(1) Includes employee stock-based

compensation charges of:

Research and development $809 $734 $1,389 $1,261

Selling, general, and

administrative 3,444 2,900 8,080 5,365

------ ------ ------ ------

$4,253 $3,634 $9,469 $6,626

------ ------ ------ ------

ONYX PHARMACEUTICALS, INC.

CALCULATION OF NET REVENUE FROM UNCONSOLIDATED JOINT BUSINESS

(In thousands, unaudited)

Three Months Ended Six Months Ended

------------------ ----------------

Jun. 30, Jun. 3
'/>"/>

SOURCE Onyx Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
2. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
5. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
6. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
7. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
8. Poniard Pharmaceuticals Announces Participation in Upcoming Conferences
9. NovaQuest Advances Virtual Development Model With Strategic Investment in TOPIGEN Pharmaceuticals
10. Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN)
11. Sunesis Pharmaceuticals Announces Reorganization to Focus Resources and Build Value in Clinical-Stage Programs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... (PRWEB) May 05, 2015 RURO, Inc., ... released FreezerPro® version 7, the latest major content upgrade ... Upgrade is a significant advancement ... succeeds in enhancing users experience, while also simplifying ... reduces system requirements , Download available immediately ...
(Date:5/5/2015)...  Blueprint Medicines (NASDAQ: BPMC ) today ... of 9,367,708 shares of common stock at a ... shares of common stock issued upon the full ... purchase additional shares. The gross proceeds from the ... $168.6 million, before underwriting discounts and estimated offering expenses. ...
(Date:5/5/2015)... SAN DIEGO AND TORONTO, May 5, 2015 /PRNewswire/ - Aptose ... "Company") today reported financial results for the three months ... Unless specified otherwise, all amounts are in Canadian dollars. ... changed its fiscal year end from May 31 to ... current interim period being reported is for the three ...
(Date:5/5/2015)... WARREN, N.J. , May 5, 2015 Roka ... focused on providing advanced testing solutions for the detection of ... will present at the Bank of America Merrill Lynch 2015 ... conference will be held at Encore at the Wynn, ... live webcast of the presentation will be available through the ...
Breaking Biology Technology:RURO Releases version 7 of FreezerPro® software 2Blueprint Medicines Announces Closing of Initial Public Offering 2Aptose Biosciences Reports Results for the First Quarter Ended March 31, 2015 2Aptose Biosciences Reports Results for the First Quarter Ended March 31, 2015 3Aptose Biosciences Reports Results for the First Quarter Ended March 31, 2015 4Aptose Biosciences Reports Results for the First Quarter Ended March 31, 2015 5Aptose Biosciences Reports Results for the First Quarter Ended March 31, 2015 6Aptose Biosciences Reports Results for the First Quarter Ended March 31, 2015 7Aptose Biosciences Reports Results for the First Quarter Ended March 31, 2015 8
... University of Technology in the Netherlands and Toyota Europe ... by the absorption of a single light particle in ... be harvested in solar cells with increased efficiency. The ... the scientific journal Nano Letters . A ...
... Inc. (Nasdaq: SGMO ) announced today that Edward ... the progress of Sangamo,s ZFP Therapeutic® development programs and an ... on Friday, October 21, 2011 at the 18th Annual Newsmakers ... New York City. The presentation will be webcast ...
... 14, 2011 /PRNewswire-Asia-FirstCall/ -- China Cord Blood Corporation (NYSE: ... largest cord blood banking operator in China, today announced that the ... Hong Kong office at 48/F, Bank of China Tower, 1 Garden ... December 19, 2011 (8:00 a.m. U.S. Eastern Time on December 19, ...
Cached Biology Technology:Three for the price of one - mobile electrons multiplied in quantum dot films 2Sangamo BioSciences Announces Presentation at the 18th Annual Newsmakers in the Biotech Industry Conference 2China Cord Blood Corporation to Hold Annual General Meeting in Hong Kong on December 19, 2011 2
(Date:5/5/2015)... 5, 2015, NXT-ID, Inc. (NASDAQ: NXTD ) ... the growing mobile commerce market, reminds investors and media that ... is presenting  at CARTES SECURE CONNEXIONS AMERICA 2015, held in ... The three-day conference is organized into a series ... is themed Global Fraud: Where is the Trust in ...
(Date:4/27/2015)... , April 27, 2015  For more than four ... show has been the premier worldwide event for the ... is a must-attend event for any local, national, or ... the emerging commercial markets and current applications of unmanned ... of this projected $48 billion industry, and how it ...
(Date:4/27/2015)... , Apr. 27, 2015 NXT-ID, Inc. ... biometric authentication company focused on the growing mobile commerce ... shipping to pre-order customers the first week of May, ... the month of May. Gino ... significant milestone for the company as Wocket® enters the ...
Breaking Biology News(10 mins):NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 2NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 3UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 2UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 3UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 4UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 5Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 2Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 3
... Spring Harbor Laboratory will host the inaugural conference ... project to create a virtual center in cyberspace ... conference, titled "Bringing Plant and Computing Scientists Together ... for April 7-9, 2008, will take the first ...
... DALLAS April 4, 2008 Researchers at UT ... method to screen small synthetic molecules and pull out ... less expensively than current methods. In one screen ... new technique quickly singled out five promising candidates that ...
... tablets, might not be that beneficial for the majority ... access journal Genome Biology. Although this trace element is ... we have lost some of the need for selenium, ... plasma, when our evolutionary ancestors left the oceans and ...
Cached Biology News:iPlant Kickoff Conference at CSHL begins tackling plant biology's grand challenges 2iPlant Kickoff Conference at CSHL begins tackling plant biology's grand challenges 3Synthetic molecules may be less expensive alternative to therapeutic antibodies, researchers find 2Synthetic molecules may be less expensive alternative to therapeutic antibodies, researchers find 3Supplements are not nutritious 2